PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 52 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $56,000 | -70.8% | 320,642 | 0.0% | 0.00% | – |
| Q2 2022 | $192,000 | -54.6% | 320,642 | 0.0% | 0.00% | – |
| Q1 2022 | $423,000 | -42.1% | 320,642 | +14.4% | 0.00% | – |
| Q4 2021 | $731,000 | -16.2% | 280,403 | -0.1% | 0.00% | – |
| Q3 2021 | $872,000 | +19.8% | 280,589 | +43.3% | 0.00% | – |
| Q2 2021 | $728,000 | -12.8% | 195,860 | -18.9% | 0.00% | – |
| Q1 2021 | $835,000 | +7.2% | 241,513 | +4.1% | 0.00% | – |
| Q4 2020 | $779,000 | -6.0% | 232,036 | -1.8% | 0.00% | – |
| Q3 2020 | $829,000 | -20.2% | 236,192 | +4.5% | 0.00% | – |
| Q2 2020 | $1,039,000 | +46.3% | 225,934 | +5.3% | 0.00% | – |
| Q1 2020 | $710,000 | -69.4% | 214,659 | -43.4% | 0.00% | – |
| Q4 2019 | $2,318,000 | +205.0% | 379,434 | +108.1% | 0.00% | – |
| Q3 2019 | $760,000 | -68.2% | 182,346 | +0.1% | 0.00% | -100.0% |
| Q2 2019 | $2,389,000 | +229.5% | 182,095 | +138.6% | 0.00% | – |
| Q1 2019 | $725,000 | – | 76,304 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|